ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680553 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680553; 2) Community: the network communities that were significantly associated with the response to NSC 680553; 3) Molecule: the relationships between components within communities and NSC 680553; 4) MDR: the compounds that were significantly associated with the NSC 680553.

NSC Compound Enrichment Correlation
NSC 681639 Camptothecin Derivative 0.0421163101172308 0.041908262
NSC 683414 Null 0.0421163101172308 -0.031265719
NSC 683662 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[2-(dimethylamino)-1-oxoethoxy]-19-[(2-propenyl)amino]-, stereo 0.0421163101172308 -0.32107618
NSC 684902 Null 0.0421163101172308 -0.12832176
NSC 686550 Butanamide, N-(3-chloro-1,4-dioxo-2-naphthalenyl)- N-(1-oxobutyl)- 0.0421163101172308 -0.21718895
NSC 692641 Null 0.0421163101172308 -0.16153514
NSC 694002 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 3H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0421163101172308 -0.19763383
NSC 694501 Null 0.0421163101172308 -0.013322206
NSC 698408 Null 0.0421163101172308 -0.095365211
NSC 702734 Null 0.0421163101172308 -0.21053873
Total:97  Current:89    [First] [Prev] [Next] [Last]